Literature DB >> 27250580

Gastric carcinosarcoma with rhabdomyosarcomatous differentiation: a case report and review.

Masashi Fujiie1, Manabu Yamamoto2, Kenichi Taguchi3, Ayako Iwanaga1, Kippei Ohgaki1, Akinori Egashira1, Kazuhito Minami1, Yasushi Toh1, Yoshinao Oda4, Takeshi Okamura1.   

Abstract

We report an unusual case of gastric carcinosarcoma with rhabdomyosarcomatous and neudoendocrinal differentiation in a 71-year-old Japanese female. Gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation is a rare tumor. The tumor developed in the body of the stomach and was exophytic in appearance. By histochemical analysis, the tumor was shown a part of positive for desmin and myoglobin and a part of positive for synaphtophysin and vimentin.We conclude that, though rare, gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation thus is reviewed in the English literatures.

Entities:  

Keywords:  Gastric carcinosarcoma; Neuroendocrine; Rhabdomyosarcomatous

Year:  2016        PMID: 27250580      PMCID: PMC4889528          DOI: 10.1186/s40792-016-0176-z

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


Background

Carcinosarcomas are rare, malignant, biphasic tumors. In the upper gastrointestinal tract, they are most frequently observed in the esophagus, while localization in the stomach has been less frequently reported [1-3]. We present a case of a 71-year-old female having gastric carcinosarcoma with rhabdomyosarcomatous and neudoendocrinal differentiation. Rhabdomyosarcomatous differentiation of the stomach is a rare neoplasm with only twelve cases previously reported [4-13]. We reviewed the scientific literature pertaining to gastric rhabdomyosarcoma and identified several distinctive clinical features of this type of tumor.

Case presentation

A 71-year-old Japanese female was admitted to the National Kyushu Cancer Center in April, 2012. Anorexia and vomiting were not observed; the CEA and CA19-9 levels were below the cutoff levels. Endoscopic studies revealed a Bormann II type lesion in the middle stomach (Fig. 1); rhabdomyosarcoma was confirmed on biopsy. We performed a laparoscopic distal gastrectomy with D2 dissected lymph node on May, 2012. On macroscopic examination, a 2.0 × 1.5 cm tumoral mass was identified in the body. The tumor invaded up until the subserosa, but no lymph node metastasis was found. As a result, the operation was considered to be curative. The patient was discharged on the 14th postoperative day. She was not admitted adjuvant chemotherapy by her offer. The patient has been doing well without any recurrence for 3 years.
Fig. 1

Endoscopy showed an ulcerative lesion in the gastric body

Endoscopy showed an ulcerative lesion in the gastric body Pathologically, the tumor was identified as carcinosarcoma with skeletal muscle and neuroendocrinal differentiation. In the submucosa, there was a proliferation of oval to polygonal cells with hyperchromatic nuclei, prominent nucleoli, and a small amount of eosinophilic cytoplasm, arranged in sheets and accompanied by thin fibro-vascular septa and prominent necrosis. Mitotic figures were frequently seen. Aggregates of histiocytes and granulation tissue were recognized in the surrounding gastric wall (Fig. 2a).
Fig. 2

a Hematoxylin-stained tumor specimen. b Immunohistochemical staining for desmin, myoglobin, vimentin, and synaptophysin was positive

a Hematoxylin-stained tumor specimen. b Immunohistochemical staining for desmin, myoglobin, vimentin, and synaptophysin was positive Immunohistochemical staining was performed using the ordinary avidine-biotin-peroxidase complex, and reaction products were visualized by benzidine reaction. The sections were slightly counterstained by hematoxylin. Immunohistochemically, the tumor cells were positive for AE1/AE3, synaptophysin, desmin, and myogenin (Fig. 2b) but negative for CAM5.2, chromogranin A, S-100 protein, c-kit, and DOG1. PAX3/7-FKHR or EWS-WT1 fusion gene transcripts were not detected by RT-PCR [14, 15].

Discussion

In the Japanese and English scientific literature, about 60 cases of gastric carcinosarcoma have been reported. The most commonly reported carcinomatous component of this tumor is tubular or papillary carcinoma. The sarcomatous components have still not been adequately characterized in most of the reported cases. Distinct sarcomatous components showing heterologous differentiation such as leiomyosarcoma [4, 5, 16–19], rhabdomyosarcoma [4–13, 20], osteosarcoma [5, 9, 21], and chondrosarcoma [5, 22–24] have been reported. In our patient, not only rhabdomyoblastic differentiation but also neuroendocrine features were observed. This association of rhabdomyosarcomatous and neuroendocrinal differentiation has been described in only five cases of carcinosarcoma, affecting the pancreas [25], larynx [26], ileum [27], nanorectal junction [28], and stomach [12]. This case is the second report on gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation. There is no indication that the gastric rhabdomyomatous component of gastric carcinosarcoma in our case or in other case reports represented a from some other site; indeed, metastases to the stomach by rhabdomyosarcomas are uncommon. De la Monte et al. reported that no instances of metastasis to the stomach in a review of 17 autopsies of 22 patients who died of embryonal and alveolar rhabdomyosarcoma at Johns Hopkins Hospital between 1929 and 1983 [29]. Gastric carcinosarcoma with rhabdomyosarcomatous differentiation has been reported in twelve cases (Table 1) [4-13]. In these twelve cases, no clinical feature has been associated with age, sex, or location. However, most cases showed a polypoid lesion, and in three of the 12 cases, it was recognized in the remnant stomach. There are cases which had poor prognosis. Actually, three of eight cases, which could confirm their survivals, were died within 1 year. The tendency of gastric rhabdomyosarcoma to metastasize to lymph node and lungs is in agreement with previous observations of rhabdomyosarcoma emerging at other sites [30].
Table 1

Reported cases of gastric carcinosarcoma with rhabdomyosarcomatous differentiation

AuthorAge/sexLocationSize (cm)Gross featureDepth of invasionOther specified histologyOutcome
carcinomasarcoma
Stout (1953) [8]Submucosa
Stout (1953) [8]Submucosa
Kyogoku (1960) [4]49/MLeiomyosarcoma FibrosarcomaDead, 36 mon
Matsukuma (1977) [9]74/MRemnant S15 × 11PolypoidSerosaMuscularis propriaOsteosarcoma FibrosarcomaDead, 5 mon (Liver meta)
Machida (1981) [7]39/FCardia7.0 × 6.0PolypoidSubmucosaSubmucosaChondrosarcoma LeiomyosarcomaDead, 5mon
Fox (1990) [10]68/FBody15 × 10PolypoidMucosaDead, 26 mon
Sugai (1991) [11]78/MPylorus9.0 × 7.0PolypoidSerosaSpindle cell sarcomaDead, 5 mon
Melato (1993) [5]73/MRemnant S7.0 × 5.5PolypoidSerosaSerosaFibrosarcoma Chondrosarcoma
Nakayama(1997) [6]69/MRemnant S20 × 18PolypoidOsteoblasticAutopsy (Pheumonia)
Tsuneyama(1999) [12]63/MPylorus7.0 × 6.5PolypoidSubserosaNeuroendocrine tumorAlive 10 mon
Sato Y (2001) [13]67/FFundus8.0 × 7.0PolypoidAdenosquamous caAlive 11 mon
Surg Case report 2016 (In press)71/FBody2.0 × 1.5PolypoidSubserosaSubserosaNeuroendocrine tumorAlive, 36 mon

Remnant S Remnant stomach

Reported cases of gastric carcinosarcoma with rhabdomyosarcomatous differentiation Remnant S Remnant stomach The histogenesis of gastric carcinosarcoma remains controversial. Some authors have reported a bioclonal origin, which supports the collision tumor theory [16, 31]. Others have proposed that these tumors are monoclonal and that the sarcomatous elements originate from a common stem cell that has the ability to undergo both epithelial and mesenchymal differentiation [7, 32]. In our patient, there were occasional transitions between carcinomatous and sarcomatous components, and the immunohistochemical detection of stem in sarcomatous cells may suggest the sarcomatous differentiation of adenocarcinoma. During transdifferentiation, the occurrence of stem cells with multi-differentiation ability is capable to explain the variety of cell types observed in the present tumor. Our experience with the present case emphasizes that gastric carcinosarcoma with rhabdomyosarcomatous differentiation exhibits aggressive behavior, the tumor, however, is extremely rare.

Conclusions

This report described a very rare case of gastric carcinosarcoma with rhabdomyosarcomatous lesions. This case has survived without tumor recurrence, though most cases of gastric carcinosarcoma with rhabdomyosarcomatous were poor prognosis.

Consent for publication

Patient consent for publication of images has been given in writing.
  25 in total

1.  Well differentiated gastric adenocarcinoma with rhabdoid areas: a case report with immunohistochemical analysis.

Authors:  J A Pinto; J E González Alfonso; L González; N Stevenson
Journal:  Pathol Res Pract       Date:  1997       Impact factor: 3.250

Review 2.  Gastric carcinosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentiation.

Authors:  Y Nakayama; H Murayama; H Iwasaki; S Iwanaga; M Kikuchi; S Ikeda; M Okada; Y Iizuka; A Iwashita
Journal:  Pathol Int       Date:  1997-08       Impact factor: 2.534

3.  [Gastric carcinosarcoma. Study of a case and its possible interpretation with reference to new histogenetic theory].

Authors:  R M Tomasino
Journal:  Arch Ital Anat Istol Patol       Date:  1970

4.  Gastric adenocarcinoleiomyosarcoma: a light, electron microscopic and immunohistological study.

Authors:  S A Dundas; D N Slater; B E Wagner; P A Mills
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

5.  A case report of gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation.

Authors:  K Tsuneyama; M Sasaki; A Sabit; K Yokoi; Y Arano; T Imai; Y Nakanuma
Journal:  Pathol Res Pract       Date:  1999       Impact factor: 3.250

6.  [Carcinosarcoma of stomach. Report of a case and review of the literature (author's transl)].

Authors:  X Ayral; F Cornud; J M Favriel; L Bocquet; C Debray
Journal:  Gastroenterol Clin Biol       Date:  1980-05

Review 7.  Clinical and pathologic features of primary gastric rhabdomyosarcoma.

Authors:  K R Fox; S M Moussa; R J Mitre; B L Zidar; J J Raves
Journal:  Cancer       Date:  1990-08-15       Impact factor: 6.860

8.  The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.

Authors:  S B Lee; K A Kolquist; K Nichols; C Englert; S Maheswaran; M Ladanyi; W L Gerald; D A Haber
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

9.  A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study.

Authors:  Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2002-11-14       Impact factor: 4.064

Review 10.  Carcinosarcomas: current perspectives and an historical review of nosological concepts.

Authors:  M R Wick; P E Swanson
Journal:  Semin Diagn Pathol       Date:  1993-05       Impact factor: 3.464

View more
  4 in total

1.  Carcinosarcoma of Stomach Confined to the Mucosa.

Authors:  Hirohiko Kuroda; Hiroaki Saito; Yusuke Kono; Yuki Murakami; Yuji Shishido; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Kanae Nosaka; Yoshihisa Umekita; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2018-02-05       Impact factor: 1.641

2.  Carcinosarcoma of the stomach: four cases that expand the morphologic spectrum of gastric cancer with a primitive phenotype.

Authors:  Sho Yamazawa; Tetsuo Ushiku
Journal:  Virchows Arch       Date:  2022-03-03       Impact factor: 4.064

3.  Computed Tomography Features and Clinicopathological Characteristics of Gastric Sarcomatoid Carcinoma.

Authors:  Yi-Yang Liu; Pan Liang; Kai-Xiang Feng; Kui-Sheng Chen; Song-Wei Yue; Jiang Ji; Wei-Wei Li; Xi-Tong Zhao; Jian-Bo Gao
Journal:  Front Oncol       Date:  2020-08-11       Impact factor: 6.244

4.  Carcinosarcoma and sarcomatoid carcinoma of the stomach: Two case reports.

Authors:  Youpeng Li; Li Cui; Ying Chen; Furong Wang
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.